Literature DB >> 30206638

Nail Involvement as a Predictor of Disease Severity in Paediatric Psoriasis: Follow-up Data from the Dutch ChildCAPTURE Registry.

Inge M G J Bronckers1, Finola M Bruins, Maartje J van Geel, Hans M M Groenewoud, Wietske Kievit, Peter C M van de Kerkhof, Marcel C Pasch, Elke M G J de Jong, Marieke M B Seyger.   

Abstract

Little is known about the relationship between nail psoriasis and psoriasis severity in children, and there has been no longitudinal assessment of psoriasis severity related to nail psoriasis. The aim of this study was to assess whether nail psoriasis could serve as a predictor for a more severe disease course. De-identified data were obtained from the ChildCAPTURE registry, a daily clinical practice cohort of children with psoriasis, from September 2008 to November 2015. Cross-sectional analyses were performed at baseline. Longitudinal data until 2-year follow-up were analysed by linear mixed models. Nail psoriasis was present in 19.0% of all 343 patients at baseline and cross-sectionally associated with higher Psoriasis Area and Severity Index (PASI) (p = 0.033). Longitudinal analysis demonstrated higher PASI (p <0.001) during 2-year follow-up in patients with nail involvement at baseline. These findings suggest that nail psoriasis is a potential clinical predictor for more severe disease course over time in paediatric psoriasis.

Entities:  

Keywords:  nail psoriasis; pediatric psoriasis; psoriasis severity; paediatric psoriasis

Mesh:

Year:  2019        PMID: 30206638     DOI: 10.2340/00015555-3036

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   4.437


  4 in total

1.  Skin Surface Protein Detection by Transdermal Analysis Patches in Pediatric Psoriasis.

Authors:  Mirjam J Schaap; Finola M Bruins; Xuehui He; Kadri Orro; Malou Peppelman; Piet E J van Erp; Elke M G J de Jong; Hans J P M Koenen; Ellen H van den Bogaard; Marieke M B Seyger
Journal:  Skin Pharmacol Physiol       Date:  2021-05-20       Impact factor: 3.479

2.  Higher rates of skin clearance and efficacy in challenging body areas are associated with better health-related quality of life following ixekizumab maintenance treatment in pediatric patients with plaque psoriasis.

Authors:  Adelaide A Hebert; Margaret A Bobonich; Claudia Rodriguez Capriles; Gaia Gallo; Lingnan Li; Najwa Somani; Terri Ridenour; Yan Wang; Emily Edson-Heredia; Emily M Becker
Journal:  Pediatr Dermatol       Date:  2021-12-20       Impact factor: 1.997

Review 3.  Imaging of the nail unit in psoriatic patients:A systematic scoping review of techniques and terminology.

Authors:  Vinzent Kevin Ortner; Victor Desmond Mandel; Serena Bertugno; Peter Alshede Philipsen; Merete Haedersdal
Journal:  Exp Dermatol       Date:  2022-04-22       Impact factor: 4.511

4.  Efficacy of ixekizumab on nail psoriasis in paediatric patients with moderate-to-severe psoriasis: a post hoc analysis from IXORA-PEDS.

Authors:  M M B Seyger; A Reich; C El Baou; C Schuster; E Riedl; A S Paller
Journal:  J Eur Acad Dermatol Venereol       Date:  2021-08-27       Impact factor: 9.228

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.